Great Lakes Heart Center of Alpena

Alpena, Michigan 49707

0 studies enrolling now · 7 studies all time

What they study most

Acute Coronary Syndromes, Atrial Fibrillation, Atrial Flutter, Coronary Artery Disease, Heart Failure, Hypertension

Studies at this site

• A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart — Completed
• Predischarge Initiation of Ivabradine in the Management of Heart Failure (PRIME-HF) — Completed
• Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation — Completed
• A Phase III Study of Apixaban in Patients With Atrial Fibrillation — Completed
• Safety and Tolerability of E5555 and Its Effects on Markers of Intravascular Inflammation in Subjects With Coronary Artery Disease — Completed
• DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension — Completed
• DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant Hypertension — Stopped early